Durán RV and Hall MN |
Glutaminolysis feeds mTORC1. |
2012 |
Cell Cycle |
pmid:23095634
|
Lazovic J et al. |
Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. |
2012 |
Neuro-oncology |
pmid:23090985
|
Fathi AT et al. |
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. |
2012 |
Blood |
pmid:23074281
|
Yang H et al. |
IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. |
2012 |
Clin. Cancer Res. |
pmid:23071358
|
Sasaki M et al. |
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. |
2012 |
Genes Dev. |
pmid:22925884
|
Yang M et al. |
The emerging role of fumarate as an oncometabolite. |
2012 |
Front Oncol |
pmid:22866264
|
Li Y et al. |
Combined inactivation of the Clostridium cellulolyticum lactate and malate dehydrogenase genes substantially increases ethanol yield from cellulose and switchgrass fermentations. |
2012 |
Biotechnol Biofuels |
pmid:22214220
|
Borger DR et al. |
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. |
2012 |
Oncologist |
pmid:22180306
|
Luchman HA et al. |
An in vivo patient-derived model of endogenous IDH1-mutant glioma. |
2012 |
Neuro-oncology |
pmid:22166263
|
Borodovsky A et al. |
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2. |
2012 |
Curr Opin Oncol |
pmid:22080945
|